Background
Multi‐b diffusion‐weighted hyperpolarized‐gas MRI measures pulmonary airspace‐enlargement using apparent diffusion coefficients (ADCs) and mean‐linear‐intercepts (Lm).
Purpose
To develop single‐breath 3D multi‐b diffusion‐weighted 3He and 129Xe MRI using k‐space undersampling. Rapid, cost‐efficient, single‐breath acquisitions may facilitate clinical translation.
Study Type
Prospective.
Subjects
We evaluated 12 participants, including nine subjects (mean age = 69 ± 9) who were included in the retrospective experiment and three chronic pulmonary obstruction disease (COPD) patients (mean age = 81 ± 6) who participated in the prospective study.
Field Strength
A whole‐body 3 T 2D/3D fast gradient recall echo (FGRE) sequence.
Assessment
Hyperpolarized 3He/129Xe MRI, spirometry, plethysmography computed tomography (CT). We evaluated 129Xe ADC/morphometry estimates by retrospectively undersampling previously acquired fully sampled multibreath, multi‐b diffusion‐weighted data. Next, we prospectively evaluated the feasibility of accelerated (AF = 7) 3He MRI static‐ventilation/T2* (extra short‐TE, b = 0 image) and ADC/morphometry (five b‐values) maps using a single gas‐dose and 16‐second breath‐hold. To conservatively evaluate cost‐improvement, we compared total costs of single vs. multiple 129Xe doses.
Statistical Tests
Multivariate analysis of variance, independent t‐tests and voxel‐by‐voxel basis difference test.
Results
For the retrospectively undersampled 129Xe data, a nonsignificant mean difference for ADC/Lm of 14%/12%, 12%/8%, and 11%/9% was observed (all, P > 0.4) between the fully sampled and accelerated data for the never‐smoker, COPD, and alpha‐1 antitrypsin deficiency (AATD) groups, respectively. The control never‐smoker group had significantly lower ADC (P < 0.001) and Lm (P < 0.001) than the COPD/AATD group for both fully sampled and accelerated data. For the prospectively acquired 3He MRI data, static‐ventilation, T2*, ADC, and morphometry maps were acquired using a single 16‐second breath‐hold scan and single gas dose. Accelerated imaging resulted in cost savings of ~$US 1000/patient, a conservative estimate based on 129Xe MRI dose savings (single vs. five doses).
Data Conclusion
This is a proof‐of‐concept demonstration of accelerated (7×) morphometry that shows that less cost‐ and time‐efficient multibreath methods that lead to variability and patient fatigue may be avoided in the future.
Level of Evidence: 2
Technical Efficacy: Stage 5
J. Magn. Reson. Imaging 2018.